-
Loading metrics
Combining MEK and SRC inhibitors for treatment of colorectal cancer demonstrate increased efficacy in vitro but not in vivo
- Fan Fan ,
- Susmita Ghosh ,
- Reid Powell,
- Jason Roszik,
- Yongsun Park,
- Mary Sobieski,
- Alexey Sorokin,
-
Clifford Stephan,
Roles Formal analysis, Methodology, Supervision
Affiliation Center for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M University, College Station, Texas, United States of America
⨯ - Scott Kopetz,
- Lee M. Ellis,
-
Rajat Bhattacharya
Roles Conceptualization, Funding acquisition, Investigation, Supervision, Writing – original draft, Writing – review & editing
* E-mail: rbhattacharya@mdanderson.org
Affiliation Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas, United States of America
⨯
https://orcid.org/0000-0003-0657-6484
Combining MEK and SRC inhibitors for treatment of colorectal cancer demonstrate increased efficacy in vitro but not in vivo
- Fan Fan,
- Susmita Ghosh,
- Reid Powell,
- Jason Roszik,
- Yongsun Park,
- Mary Sobieski,
- Alexey Sorokin,
- Clifford Stephan,
- Scott Kopetz,
- Lee M. Ellis
x
- Published: March 23, 2023
- https://doi.org/10.1371/journal.pone.0281063